Phase II clinical trial - VADS
DEBIO 1143-202
VADS
Essai clinique fermé
Public cible
Adulte
Pre-operative window-of-opportunity study of Debio 1143 with or without cisplatin in patients with resectable squamous cell carcinoma of the head and neck.
Description de l'essai
This is a trial for head and neck cancer patients who will get primary surgery. Patients receive before surgery 2 weekly injections of cisplatine in combination with an oral targeted therapy.
![CHRISTOPHE LE TOURNEAU Vignette](/sites/default/files/styles/carre_petit/public/annuaire/00001880-65685c7429b0b.jpg?h=f0e6b76b&itok=xM0M-iya)
CHRISTOPHE LE TOURNEAU
Investigateur principal